Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banu Atalar

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 30, 2020
Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical stagingMelis Gultekin, Ozan Cem Guler, Sezin Yuce Sari, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 4, 2020
Treatment outcomes of metastasis-directed treatment using <sup>68</sup>Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)Pervin Hurmuz, Cem Onal, Gokhan Ozyigit, et al.
Rare Tumors|October 3, 2014
The rare cancer network: ongoing studies and future strategyMahmut Ozsahin, René-Olivier Mirimanoff, Juliette Thariat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2018
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experienceBanu Atalar, Mahmut Ozsahin, Jason Call, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2025
Understanding national Societies' needs and enhancing collaboration with ESTRO: A report of the national Societies survey 2024, on behalf of the ESTRO national Societies committeeBanu Atalar, Federico Mastroleo, Mattia Zaffaroni, et al.
Advances in Respiratory Medicine|November 5, 2019
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithmMutlay Sayan, Mehmet Fuat Eren, Apar Gupta, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 23, 2020
Impact of Prolonged Neoadjuvant Treatment-surgery Interval on Histopathologic and Operative Outcomes in Patients Undergoing Total Mesorectal Excision for Locally Advanced Rectal CancerAta C Akbaba, Serkan Zenger, Erman Aytac, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 24, 2025
Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) studyŞefika Arzu Ergen, Fazilet Öner Dinçbaş, Evrim Metcalfe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 19, 2024
Multi-institutional analysis of extracranial oligometastatic colorectal cancer patients treated with stereotactic body radiation therapy: TROD 02-008 studyOzan Cem Guler, Pervin Hurmuz, Banu Atalar, et al.
The Clinical Respiratory Journal|August 5, 2020
Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric StudyBilgehan Sahin, Banu Atalar, Esra Kaytan Saglam, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 30, 2020
Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical stagingMelis Gultekin, Ozan Cem Guler, Sezin Yuce Sari, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 4, 2020
Treatment outcomes of metastasis-directed treatment using <sup>68</sup>Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)Pervin Hurmuz, Cem Onal, Gokhan Ozyigit, et al.
Rare Tumors|October 3, 2014
The rare cancer network: ongoing studies and future strategyMahmut Ozsahin, René-Olivier Mirimanoff, Juliette Thariat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 27, 2018
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experienceBanu Atalar, Mahmut Ozsahin, Jason Call, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 30, 2025
Understanding national Societies' needs and enhancing collaboration with ESTRO: A report of the national Societies survey 2024, on behalf of the ESTRO national Societies committeeBanu Atalar, Federico Mastroleo, Mattia Zaffaroni, et al.
Advances in Respiratory Medicine|November 5, 2019
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithmMutlay Sayan, Mehmet Fuat Eren, Apar Gupta, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 23, 2020
Impact of Prolonged Neoadjuvant Treatment-surgery Interval on Histopathologic and Operative Outcomes in Patients Undergoing Total Mesorectal Excision for Locally Advanced Rectal CancerAta C Akbaba, Serkan Zenger, Erman Aytac, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 24, 2025
Failure patterns and the influence of the TNM staging systems on prognosis in limited disease small cell lung Cancer (SCLC): the Turkish Oncology Group (TOG) studyŞefika Arzu Ergen, Fazilet Öner Dinçbaş, Evrim Metcalfe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 19, 2024
Multi-institutional analysis of extracranial oligometastatic colorectal cancer patients treated with stereotactic body radiation therapy: TROD 02-008 studyOzan Cem Guler, Pervin Hurmuz, Banu Atalar, et al.
The Clinical Respiratory Journal|August 5, 2020
Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric StudyBilgehan Sahin, Banu Atalar, Esra Kaytan Saglam, et al.
Pageof 7